How to Buy Embecta Stock
Embecta Corp
Embecta Corp. , a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
Embecta stock last closed at $9.56, down 4.78% from the previous day, and has decreased 26.8% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.24 percentage points. Embecta stock is currently +0.05% from its 52-week low of $9.56, and -55.49% from its 52-week high of $21.48.
At the moment, there are 58.44M EMBC shares outstanding. The market cap of EMBC is $558.71M. In the past 24 hours, 482,000 EMBC shares were traded.
How to Buy Embecta Stock
Wondering how to invest in Embecta stock? Here's how.
- Choose where to buy Embecta stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Embecta stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Select your payment method and add your information.
- Research Embecta stock: The Embecta ticker symbol is EMBC. Is Embecta stock a good investment? Should you buy shares of EMBC? How do EMBC's underlying business fundamentals look? Do top analysts think Embecta is a good buy? Why has EMBC's stock price moved recently? (Hint: Our stock research website can help you figure out if EMBC is a good stock to buy).
- Place your EMBC trade: Decide if you will purchase EMBC shares at the current market price or use a limit order to buy EMBC stock at a particular price.
- Get key alerts regarding your EMBC position: Create a watchlist to the latest updates on your new investment in Embecta stock.
Step 1: Choose where to buy Embecta stock
You will need an online brokerage account to access the NASDAQ market and buy EMBC stock.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal information so you can buy EMBC today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start your new brokerage account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on app for investing, your next step is to transfer the money for your investment:
Check out the video below if you need help transferring funds into your investment account.
Step 4: Research Embecta stock
Once you have selected the best place to buy Embecta stock, it's absolutely critical to research their stock prior to investing, so you actually wrap your head around the risk as well as the opportunity.
Embecta shares at a glance
Embecta Due Diligence Checks
WallStreetZen was created to help everyday investors do more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on EMBC's stock page.
Is EMBC stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge EMBC's fair value.
Using relative valuations metrics:
- EMBC could be undervalued based on its P/E ratio of 10.62x, relative to Medical Instruments & Supplies industry P/E ratio of 38.52x
- EMBC could be undervalued based on its PEG ratio of 0.22x
You can access additional valuation analysis on EMBC's stock here.
EMBC Financials at a glance
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the EMBC balance sheet.
Negative Health Checks:
- Total EMBC debt is still negative.
- EMBC's operating cash flow of $35.70M allows it to safely service it's debt of $1.55B.
- There are more long-term liabilities than short-term assets on the EMBC balance sheet.
- EMBC earnings of $166.50M is not sufficient to cover its interest payments.
- EMBC profit margin has gone down from 6.2% to 4.9% in the past year.
- EMBC debt to equity ratio of -2.52 is negative.
Do Wall Street analysts think it's a good time to buy EMBC stock
Out of 1 Equities analysts who research EMBC, the consensus analyst rating on EMBC is a Hold
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Embecta stock forecast page.
EMBC Trading Indicators
EMBC Earnings
Last year, EMBC earnings were $52.80M. Over the last three year, EMBC's earnings have grown by -95.31% per year. This was slower than the Medical Instruments & Supplies industry average of 20.76%.
Last year, EMBC revenue was $1.08B. During the past three year, EMBC's revenue has increased by -41.03% per year. This was slower than the Medical Instruments & Supplies industry average of 10.32%.
Dig into EMBC's earnings and revenue performance here.
What are EMBC insiders up to?
Over the past year, insiders at EMBC have sold more shares than they have bought.
David F. Melcher, Director of EMBC, was the latest EMBC insider to buy. They bought $106,000.00 worth of EMBC stock on May 23, 2025.
Research more about who owns EMBC stock here.
Can I rely on EMBC as an income stream?
Embecta pays a dividend of 4.71%, compared to the Medical Instruments & Supplies industry's average dividend yield of 1.77%. If you owned $1,000 worth of EMBC stock, you would have received $47.07 in the past year.
Get more info about Embecta dividend yield and history here.
What do other traders have to say about EMBC?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your EMBC trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you require more help with buying stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your EMBC position
Now that you own some EMBC stock, you'll want to keep up with your investment.
Create a watchlist to get notified of important updates regarding your EMBC stock.
EMBC Feed
How to Buy Stock in Embecta
To summarize, here are the 6 steps to buy Embecta stock:
- Choose where to buy Embecta stock
- Open a brokerage account
- Deposit funds into your investment account
- Research Embecta stock
- Place your EMBC trade
- Get key alerts regarding your EMBC position
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Embecta, create a watchlist today.
Other "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.